Xcout Intel
UCB
UCB is a global biopharmaceutical company that researches, develops, and delivers medicines and solutions for patients living with severe neurological and autoimmune conditions. It serves individuals with chronic and rare diseases as well as healthcare professionals through treatments, clinical studies, and support services.
Subscribe to see UCB’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
UCB at a glance
UCB is a pharmaceuticals company headquartered in Blairsville, Belgium. Xcout tracks 12 named people at UCB, including Herbert Lynn Harton (President, Chairman & CEO).
UCB leadership
- Herbert Lynn HartonPresident, Chairman & CEO
- Jean-Christophe TellierCEO
- Richard William BradshawPresident & Chief Banking Officer
- Jefferson Lee HarralsonExecutive Vice President & Chief Financial Officer
- Melinda Davis LuxChief Administrative Officer, General Counsel & Corporate Secretary
- Robert A. EdwardsExecutive Vice President & Chief Risk Officer
6 more named people on record for UCB, with roles, board committees and tenure — see the full roster →
Recent UCB news
Get UCB's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on UCB in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access